Udomsak Bunworasate

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris, Rachel Young, Steven M. Devine et al. · Biology of Blood and Marrow Transplantation · 2015 · 882 citations · Full text

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

Matthew J. Hartwell, Umut Özbek, Ernst Holler et al. · JCI Insight · 2017 · 218 citations · Full text

Extranodal NK/T-cell Lymphoma, Nasal Type, Includes Cases of Natural Killer Cell and αβ, γδ, and αβ/γδ T-cell Origin

Tawatchai Pongpruttipan, Sanya Sukpanichnant, Thamathorn Assanasen et al. · The American Journal of Surgical Pathology · 2012 · 204 citations

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma

Chantana Polprasert, Yasuhide Takeuchi, Nobuyuki Kakiuchi et al. · Blood Advances · 2019 · 100 citations · Full text